EMJ GOLD

Catch up on the biggest stories to hit the pharmaceutical industry in September in the latest edition of our Spotlight series. Inside, discover Genentech's investment in Regor Pharmaceuticals, Gilead Sciences' new licensing agreements for HIV prevention, Boehringer Ingelheim's partnership with the WHO Foundation and much more. Read on: https://hubs.la/Q02X4p9n0

AstraZeneca's early phase weight-loss pill, licensed from China’s Eccogene last year for $2bn, has shown initial promise in a Phase I trial. Discover more: https://hubs.la/Q02W_1YY0

Yesterday, Isabel O'Brien and Jade Williams swapped GOLD HQ for Reuters Events Pharma Customer Engagement 2024! From actionable strategies to thought-provoking insights, check out their round-up below: An early session we enjoyed was with Roche’s Richard Wright on designing customer experiences that truly support business goals. His advice? Don’t make “enhancing CX” the goal. Instead, define your business outcomes, identify the behaviours needed to achieve them and then shape customer experiences to drive those behaviours. Also in a panel exploring the roadmap to next-generation customer engagement, Rodney B. Smith, Daiichi Sankyo, reinforced the fact that “if you don’t bring value, you’re not going to get additional time with your customers”. In an industry where time with the customer is so scarce, every interaction must be worthwhile to lead to another. Another highlight came from friend of EMJ GOLD, Martina Dempsey, Astellas Pharma, whose presentation revealed that only 27% of HCPs find biopharma communications relevant and personalised. With 75% more therapeutic area content available today than a decade ago, she emphasised that getting omnichannel right can be the key to success. Finally, behaviour change was the focus of an insightful presentation by Ben Myall, CEO, Everybody Agency. Using the powerful example of HRT, he presented a framework for reducing the biases that can distort prescribing decisions or reduce the importance attached to certain conditions. A great lesson in understanding the why of decision making. #REcustomerEU24

In a sustainability win for pharmaceutical packaging, UPM - The Biofore Company, Selenis Specialty Polyester Solutions and Bormioli Pharma have launched the industry's first bottle made from wood-based PET. Read more here: https://hubs.la/Q02WN6hf0

Revisit the 'blue tick' scandal that shook the pharma industry's confidence in Twitter—now X. How did it all unfold, and where did it leave industry opinions? Read it here: https://hubs.la/Q02WCzk_0

How can #pharma companies best leverage their #KOLs earlier in the product lifecycle, and how do KOLs themselves want to be involved? Find out on GOLD: https://hubs.la/Q02WD1SD0

Three companies, Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups in a survey by PatientView. Find out why: https://hubs.la/Q02WCFYv0

How is technology solving emerging challenges in healthcare?: https://hubs.la/Q02WqBWz0 Find out in the latest edition of our spoonful of technology, covering a new appointment for Eli Lilly, DTX apps from PursueCare and insights on how to engage HCPs beyond the congress hall. Read the full edition here: https://hubs.la/Q02WqBWz0

Why is the new Budget good news for life sciences in the UK? Uncover all you need to know in this news story, including why it has been welcomed by Richard Torbett MBE and the The Association of the British Pharmaceutical Industry (ABPI): https://hubs.la/Q02Wl41j0

Why do women with rare diseases face more barriers to care, and what can be done to change this? Find out what Jennifer Schranz M.D., Ipsen thinks in the latest episode of the podcast, where she and Jade sit down to discuss how the industry can lessen the double jeopardy facing women with rare diseases. Watch her full interview here: https://hubs.la/Q02W8l_d0